Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens

Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimensLow-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens, Published online: 19 October 2018; doi:10.1038/s41408-018-0134-zLow-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens

Source: Blood Cancer Journal - October 19, 2018 Category: Hematology Authors: George Z. Rassidakis Nikolas Herold Ida Hed Myrberg Nikolaos Tsesmetzis Sean G. Rudd Jan-Inge Henter Torsten Schaller Siok-Bian Ng Wee Joo Chng Benedict Yan Chin Hin Ng Farhad Ravandi Michael Andreeff Hagop M. Kantarjian L. Jeffrey Medeiros Ioanna Xagorar Source Type: research